Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 500341 - 500360 out of 505060 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| USA | (L01EJ01) ruxolitinib (adm: O) | JAKAFI 15MG TAB | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Myeloproliferative Disorders;Polycythemia Vera;Graft vs Host Disease | IncyteCorporation |
| USA | (L01EJ01) ruxolitinib (adm: O) | JAKAFI 20MG TAB | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Myeloproliferative Disorders;Polycythemia Vera;Graft vs Host Disease | IncyteCorporation |
| USA | (L01EJ01) ruxolitinib (adm: O) | JAKAFI 20MG TAB | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Myeloproliferative Disorders;Polycythemia Vera;Graft vs Host Disease | IncyteCorporation |
| USA | (L01EJ01) ruxolitinib (adm: O) | JAKAFI 25MG TAB | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Myeloproliferative Disorders;Polycythemia Vera;Graft vs Host Disease | IncyteCorporation |
| USA | (L01EJ01) ruxolitinib (adm: O) | JAKAFI 25MG TAB | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Myeloproliferative Disorders;Polycythemia Vera;Graft vs Host Disease | IncyteCorporation |
| USA | (L01EJ01) ruxolitinib (adm: O) | JAKAFI 5MG TAB | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Myeloproliferative Disorders;Polycythemia Vera;Graft vs Host Disease | IncyteCorporation |
| USA | (L01EJ01) ruxolitinib (adm: O) | JAKAFI 5MG TAB | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Myeloproliferative Disorders;Polycythemia Vera;Graft vs Host Disease | IncyteCorporation |
| USA | (L01EN02) pemigatinib (adm: O) | PEMAZYRE 13.5MG TAB | 14 | Ex-factory price without vat |
$0-0 |
$0-0 |
Cholangiocarcinoma | IncyteCorporation |
| USA | (L01EN02) pemigatinib (adm: O) | PEMAZYRE 13.5MG TAB | 14 | Ex-factory price without vat |
$0-0 |
$0-0 |
Cholangiocarcinoma | IncyteCorporation |
| USA | (L01EN02) pemigatinib (adm: O) | PEMAZYRE 4.5MG TAB | 14 | Ex-factory price without vat |
$0-0 |
$0-0 |
Cholangiocarcinoma | IncyteCorporation |
| USA | (L01EN02) pemigatinib (adm: O) | PEMAZYRE 4.5MG TAB | 14 | Ex-factory price without vat |
$0-0 |
$0-0 |
Cholangiocarcinoma | IncyteCorporation |
| USA | (L01EN02) pemigatinib (adm: O) | PEMAZYRE 9MG TAB | 14 | Ex-factory price without vat |
$0-0 |
$0-0 |
Cholangiocarcinoma | IncyteCorporation |
| USA | (L01EN02) pemigatinib (adm: O) | PEMAZYRE 9MG TAB | 14 | Ex-factory price without vat |
$0-0 |
$0-0 |
Cholangiocarcinoma | IncyteCorporation |
| USA | (L01EX02) sorafenib (adm: O) | SORAFENIB 200MG TAB | 120 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | AvKare,LLC |
| USA | (L01EX11) quizartinib | VANFLYTA 17.7MG TAB | 14 | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Myeloid | DaiichiSankyo,Inc. |
| USA | (L01EX11) quizartinib | VANFLYTA 17.7MG TAB | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Myeloid | DaiichiSankyo,Inc. |
| USA | (L01EX11) quizartinib | VANFLYTA 17.7MG TAB | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Myeloid | DaiichiSankyo,Inc. |
| USA | (L01EX11) quizartinib | VANFLYTA 17.7MG TAB | 14 | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Myeloid | DaiichiSankyo,Inc. |
| USA | (L01EX11) quizartinib | VANFLYTA 26.5MG TAB | 14 | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Myeloid | DaiichiSankyo,Inc. |
| USA | (L01EX11) quizartinib | VANFLYTA 26.5MG TAB | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Myeloid | DaiichiSankyo,Inc. |
Pages
